Physician profile
Ajit Thota
NPI 1588185854
$4,658.14
in general payments reported to CMS, 2019-2025
21 companies · $986 in 2025
The $986 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $183 · 2021: $461 · 2022: $1,259 · 2023: $943 · 2024: $826 · 2025: $986.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,560 · Food and Beverage: $1,196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,559.53 |
| Food and Beverage | $1,195.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $2,576.62 | 2022-2025 | Single Use Suction Valve (Sterile), Olympus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $413.31 | 2020-2025 | |
| Glaxosmithkline, LLC. | $327.42 | 2020-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Mylan Specialty L.P. | $315.93 | 2020-2024 | Yupelri |
| Astrazeneca Pharmaceuticals LP | $216.04 | 2021-2025 | Airsupra, Breztri, Tezspire |
| Regeneron Healthcare Solutions, INC. | $189.44 | 2021-2025 | Dupixent |
| United Therapeutics Corporation | $89.29 | 2024-2025 | Tyvaso, Tyvaso |
| Insmed, INC. | $61.21 | 2024-2025 | Arikayce |
| Grifols USA, LLC | $59.99 | 2024-2025 | Prolastin-C Liquid |
| Genzyme Corporation | $59.01 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $56.20 | 2024-2025 | Glassia |
| Amgen INC. | $45.20 | 2024 | Tezspire |
| Ani Pharmaceuticals, INC. | $41.12 | 2025 | Purified Cortrophin Gel |
| Tactile Systems Technology INC | $38.28 | 2024 | Entre Plus, Flexitouch Plus |
| Advanced Respiratory, INC | $37.27 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $33.56 | 2024 | Smartvest |
| Verona Pharma, INC. | $30.42 | 2025 | Ohtuvayre |
| Mallinckrodt Hospital Products INC. | $20.17 | 2025 | Acthar |
| Alexion Pharmaceuticals, INC. | $17.58 | 2021 | |
| Baxter Healthcare | $16.07 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Viatris Specialty LLC | $14.01 | 2025 | Yupelri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajit Thota listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.